Global Gynecological Cancers Market 2014-2018: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Increase Web Conversions Learn how marketers like you are using real-time web personalization to drive engagement and conversions. Download today! From our sponsors

Global Gynecological Cancers Market 2014-2018 Dec 20th 2013, 00:00 TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market.TechNavio's report, the Global Gynecological Cancers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gy...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Global Dietary Fiber Market 2014-2018: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

#1 Retargeting Platform Our Average Customer Earns $10 For Every $1 Spent From our sponsors

Global Dietary Fiber Market 2014-2018 Dec 13th 2013, 00:00 TechNavio''s analysts forecast the Global Dietary Fiber market to grow at a CAGR of 15.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Dietary Fiber market has also been witnessing the increasing demand for bakery products. However, the stringent government regulations and guidelines could pose a challenge to the growth of this market. TechNavio''s report, the Global Dietary Fiber Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region and the ROW; it also covers the Global Dietary Fib...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

#1 Retargeting Platform Our Average Customer Earns $10 For Every $1 Spent From our sponsors

EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022 Dec 15th 2013, 00:00 EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022 Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes ulcers in the innermost lining of the colon and rectum. The colon?s ability to absorb water is decreased, which leads to progressive loosening of the stool, bloody stool, and sometimes cramping or abdominal pain with urgency for bowel movement (CDC, 2013; NDDIC, 2013). The exact cause or triggers of the disease are yet to be identified. Globally, the incidence of ulcerative colitis varied from 0.34 cases per 100,000 population in China to as high as 15.1 cases per 100,000 population in the UK in the 1990s (Lok et al., 2008; Sh...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Global and China Separating Membrane Industry Report, 2013-2016: Manufacturing & Construction Market Research Reports

Manufacturing & Construction Market Research Reports Manufacturing & Construction Market Research Reports XML feed

Startup Hiring: How to Hire the Best People Attract and retain the best people. 7 lectures from top founders and CEO's about how to hire for your startup! Sign up for $19. From our sponsors

Global and China Separating Membrane Industry Report, 2013-2016 Dec 25th 2013, 00:00 Separating membrance is a kind of thin-layer substance with selective penetration function. It is for the use of concentration, separation and purification, and is widely applied in the sectors such as environment, energy, chemical, electronics, pharmaceuticals and food.In 2012, the global market scale of separating membrance products approached USD12 billion, of which, the market size of reverse osmosis membrance (including nanofiltration membrance), micro-filtration membrance and ultrafiltration membrance stood at around 95%. Worldwide, industrial players from Japan and the United States play a more dominant role, cases including Toray Industries, Mitsubishi Rayon, Asahi Kasei Corporation...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Research Report on China Antidiabetic Drug Market, 2014-2018: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Research Report on China Antidiabetic Drug Market, 2014-2018 Dec 17th 2013, 00:00 In 2013, the diabetes prevalence rate of grown-ups aged in 20 to 79 was 8.3% in the globe. The number of sufferers reached 382 million. 80% of the patients lives in low to medium income countries. Meanwhile, the number of sufferers in these countries in increasing. The number of global diabetes sufferers is expected to be 592 million by 2035. In the current sufferer group, about 175 million people (46%) are not diagnosed or treated. In 2013, the global IGT prevalence rate was 6.9% and the number of sufferers was 316 million. The number is expected to be 474 million by 2035. In 2013, there were 5.1 million people died from diseases related to diabetes, accounting for 8.4% of the total death ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Injectable Generic and Biosimilar Drugs ? Potential Opportunities for Developers 2013: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

2014 Benchmark Report Learn the ecommerce metrics that matter. From our sponsors

Injectable Generic and Biosimilar Drugs ? Potential Opportunities for Developers 2013 Dec 17th 2013, 00:00 The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include Hospira, Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical Industries. But interest in generic injectables has not been limited to established generic companies, as pharmaceutical majors like Pfizer have also become attracted to the market.This is hardly surprising with a global injectables market in the region of US$144 billion. While the lion’s share remains with the innovative industry for the time being, the generic injectables market is worth a...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth Dec 17th 2013, 00:00 GBI Research has released the pharma report - Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth” Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract. They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with low survival rates in the early stages of disease. Currently the primary treatment options are chemotherapy and surgery, which are used wherever possible. One monoclonal Antibody (mAb), Herceptin (trastuzumab) is marketed for use in suitable patients with advanced gastric or gastro-eso...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth Dec 17th 2013, 00:00 GBI Research, has released the pharma report - Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix. The current market leader is Avastin, which generated revenues of $6.2 billion in 2012 across a number of oncology indications. While compelling late-stage candidates are absent from the current pipeline, the anticipated rise in total prevalence of colorectal cancer in the top eight marke...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Parkinson?s Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Get consumer insights Are consumers aware of your brand? Do they prefer your competitor? Get the answers from SurveyMonkey Audience. We have the insights you need to make better decisions From our sponsors

Parkinson?s Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management Dec 17th 2013, 00:00 GBI Research has released the pharma report - Parkinson’s Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s Disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life. There is currently there is a huge unmet need for disease-modifying treatments that slow progression or have neuroprotective properties. Over the 2012–2019 forecast period, the PD market is anticipated to decline from $3.4 billion in 2012 to $2.9 billion in 2019, as a consequenc...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Medical Devices Market Research Reports: Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) ? Global Trends & Forecast to 2018

Medical Devices Market Research Reports Medical Devices Market Research Reports XML feed

Get consumer insights Are consumers aware of your brand? Do they prefer your competitor? Get the answers from SurveyMonkey Audience. We have the insights you need to make better decisions From our sponsors

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) ? Global Trends & Forecast to 2018 Dec 17th 2013, 00:00 The global microfluidicsmarket is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years.The global microfluidics marketis categorized into materials, products, and applications segments. This report studies the market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on products, the pharmaceutical market is categorized into microfluidic chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The in-vitro diagno...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Vildagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage): Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Vildagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Cabozantinib - Key patent, SPC, and data exclusivity expiry (44 country coverage): Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-no more Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Cabozantinib - Key patent, SPC, and data exclusivity expiry (44 country coverage) Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Dexmedetomidine - Comprehensive patent search: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Dexmedetomidine - Comprehensive patent search Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage): Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Get consumer insights Are consumers aware of your brand? Do they prefer your competitor? Get the answers from SurveyMonkey Audience. We have the insights you need to make better decisions From our sponsors

Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Lanreotide - Key patent, SPC, and data exclusivity expiry (44 country coverage): Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-no more Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Lanreotide - Key patent, SPC, and data exclusivity expiry (44 country coverage) Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Ferric carboxymaltose - Comprehensive patent search: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-No More Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Ferric carboxymaltose - Comprehensive patent search Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Lanreotide - Comprehensive patent search: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

Social Media Woes-no more Stop bad reviews before they turn Hurricane Sandy on Twitter & Facebook. Freshdesk captures it all for you. Signup and see why over 10,000 businesses love Freshdesk! From our sponsors

Lanreotide - Comprehensive patent search Dec 17th 2013, 00:00 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.Pipeline Developer feat...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions